Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages.

類似資料

• SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
  著者:: Yahi, N, 等
  出版事項: (1995)
• Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
  著者:: Yahi, N, 等
  出版事項: (1995)
• Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides.
  著者:: Vives, E, 等
  出版事項: (1994)
• Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells.
  著者:: Fantini, J, 等
  出版事項: (1991)
• Comparison of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Mutations in HIV-1 Genomes Detected in Plasma and in Peripheral Blood Mononuclear Cells from Patients Receiving Combination Drug Therapy
  著者:: Koch, Nathalie, 等
  出版事項: (1999)